VENTANA hematopathology solutions: Deliver diagnostic confidence

The stated goal of the World Health Organization (WHO) classification of tumors of hematopoietic and lymphoid tissues is to define real diseases that appear to be distinct clinical entities by using all available information, including morphology, immunophenotyping, genetic features and clinical features.2 Thus, diagnosis of hematopathological cancers often requires the use of immunohistochemistry/immunophenotype information to aid in confirming or excluding a particular diagnosis. Roche Diagnostics is committed to assisting you in your quest to accurately diagnose and subtype hematopathological diseases.